NOC vs NRXS · P/E 17, rev $20.76B vs rev $3.6M
Northrop Grumman Corporation (NOC) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the NOC and NRXS stock pages for the full models.
Not investment advice.